A standardized procedure for quantitation of CD11b on polymorphonuclear neutrophil by flow cytometry: potential application in infectious diseases.
An up-regulation of the surface marker CD11b has been demonstrated during polymorphonuclear (PMN) cell activation. CD11b over-expression is often associated with inflammation and is considered as an early marker of infection. However, the absence of standardized assay and the variability of preanalytical settings leading to PMN artifactual activation have compromised the interest of this marker. In the present study a standardized quantitative flow cytometry assay directly performed in whole blood has been used to determine CD11b expression on PMN cells. The results indicate that quantitative flow cytometry can provide consistent CD11b density values between laboratories provided that a calibration system is used including specific calibrators, reagents and protocols. This method allowed us to evidence an up-regulation of CD11b expression for infected patients. This quantitation is a standardized and potentially useful method in clinical situations implying quantitative CD11b expression variations.
Latger-Cannard
V
V
Laboratory of Hematology, CHU Nancy, Vandoeuvre-lès-Nancy, France. v.latger-cannard@chu-nancy.fr
Besson
I
I
Doco-Lecompte
T
T
Lecompte
T
T
D039481:CD11b Antigen / Q000032:analysis* / Q000235:genetics; D016022:Case-Control Studies; D019411:Clinical Laboratory Techniques / Q000592:standards; D005434:Flow Cytometry / Q000379:methods; D006801:Humans; D007239:Infections / Q000175:diagnosis; D007249:Inflammation / Q000175:diagnosis; D008722:Methods; D009504:Neutrophils / Q000737:chemistry* / Q000166:cytology; D015854:Up-Regulation / Q000276:immunology
D039481:CD11b Antigen